Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542Phase 4Completed
- Sponsor
- Health Sciences North Research Institute
- Start
- Feb 2014
- Primary completion
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by Health Sciences North Research Institute. Started Feb 2014; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02297542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297542.